BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4328811)

  • 1. Detection of antigens of the mouse mammary tumor (MTV) and murine leukemia virus (MuLV) in cells of cultures derived from mammary tumors of mice of several strains.
    Hilgers J; Williams WC; Myers B; Dmochowski L
    Virology; 1971 Aug; 45(2):470-83. PubMed ID: 4328811
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on mouse mammary tumor virus (MTV) and mouse leukemia virus (MuLV) by immunoelectron microscopy.
    Shigematsu T; Dmochowski L; Williams WC
    Cancer Res; 1971 Dec; 31(12):2085-97. PubMed ID: 4330440
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural and quantitative studies of mammary tumor virus production in cultured mouse mammary tumor cells.
    Kramarsky B; Lasfargues EY; Moore DH
    Cancer Res; 1970 Apr; 30(4):1102-8. PubMed ID: 4100959
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the interrelationship of type B and type C virus particles in breast cancer and in leukemia.
    Dmochowski L
    Bibl Haematol; 1973; 39():45-60. PubMed ID: 4360177
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 7. Cultivation and characterization of BALB-cfC3H mammary tumor cell lines.
    Yagi MJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1849-60. PubMed ID: 4358145
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammary tumor virus associated antigens on the membrane of infected mouse spleen cells.
    Daams JH; Calafat J; Lasfargues EY; Kramarsky B; Bentvelzen P
    Virology; 1970 May; 41(1):184-6. PubMed ID: 4315440
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
    Yagi MJ
    Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary tumor virus (MTV) antigens in normal and mammary tumor-bearing mice.
    Hilgers JH; Theuns GJ; van Nie R
    Int J Cancer; 1973 Nov; 12(3):568-76. PubMed ID: 4364792
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic cross reactions between virus producing and non-virus producing murine mammary carcinoma].
    Zotter S; Kemmer C; Müller M; Micheel B
    Arch Geschwulstforsch; 1972; 40(1):23-34. PubMed ID: 4347235
    [No Abstract]   [Full Text] [Related]  

  • 12. Mammary tumor virus-associated antigenicity of L-1210 murine leukemia cells.
    Kisielow P; Radzikowski C; Steuden J; Szkudlarek J; Krawczynski K
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):789-99. PubMed ID: 4335186
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse mammary tumor virus and murine leukemia virus cell surface antigens on virus producer and nonproducer mammary epithelial tumor cells.
    Schochetman G; Fine DL; Massey RJ
    Virology; 1978 Jul; 88(2):379-83. PubMed ID: 211719
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological studies on mouse mammary tumors and leukemia.
    Dmochowski L; Williams WC; Swearingen GR; Myers B; Fujinaga S
    Tex Rep Biol Med; 1971; 29(1):41-62. PubMed ID: 4328256
    [No Abstract]   [Full Text] [Related]  

  • 16. A soluble antigen of the mammary tumor virus.
    Nowinski RC; Old LJ; Moore DH; Geering G; Boyse EA
    Virology; 1967 Jan; 31(1):1-14. PubMed ID: 4289349
    [No Abstract]   [Full Text] [Related]  

  • 17. Presence of the p27 antigenicity and absence of the gp52 antigenicity and leukemia virus antigens in intracytoplasmic A particles (iAp) of mouse mammary tumour origin.
    Zotter S; Kryukowa IN; Bukrinskaya AG; Lezhnewa OM; Ilyin KV; Miller GG; Müller M
    Arch Geschwulstforsch; 1976; 46(8):621-9. PubMed ID: 66045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of leukemia C particles from murine cell lines infected with Bittner virus-containing inocula.
    Lasfargues EY; Pillsbury N; Lasfargues JC; Moore DH
    Cancer Res; 1970 Jan; 30(1):167-78. PubMed ID: 4314990
    [No Abstract]   [Full Text] [Related]  

  • 19. Independence of H-2 and viral antigens on the cell surface and absence of H-2 antigens on murine leukemia virus and mouse mammary tumor virus particles.
    Calafat J; Démant P; Janssen H
    Immunogenetics; 1981; 14(3-4):203-20. PubMed ID: 6277784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
    Bowen JM; Dmochowski L; Miller MF; Priori ES; Seman G; Dodson ML; Maruyama K
    Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.